NCT05461508View on ClinicalTrials.gov

Fucoidan Assisted Eradication of Helicobacter Pylori

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

June 1, 2024

Study Completion Date

July 31, 2024

Conditions
Helicobacter Pylori InfectionIntestinal Bacteria Flora Disturbance
Interventions
BIOLOGICAL

Amoxicillin combined with vonoprazan and fucoidan

Fucoidan was used in combination with amoxicillin and vonoprazan. The purpose of this study was to explore the effect of fucoidan on the eradication rate of Helicobacter pylori and the intestinal flora of subjects.

OTHER

Amoxicillin combined with vonoprazan

Amoxicillin and vonoprazan were used as the study control group

Trial Locations (1)

210000

RECRUITING

Nanjing First Hospital, Nanjing Medical University, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER